Despite its significance as an AD risk factor, the role of APOE4, upon discovery, was mainly investigated in the context of its relationship with amyloid beta peptide biology (if at all), further demonstrating the amyloid-centric direction of AD research in the 1990s. This evidence concerns the gene APOE and Alzheimer disease.